QQQ   425.93 (+0.02%)
AAPL   167.60 (-0.24%)
MSFT   409.28 (-0.62%)
META   510.20 (+3.24%)
GOOGL   156.76 (+0.83%)
AMZN   181.81 (+0.29%)
TSLA   150.10 (-3.44%)
NVDA   857.90 (+2.09%)
AMD   156.07 (+1.33%)
NIO   4.02 (+2.81%)
BABA   69.21 (+0.57%)
T   16.20 (+0.50%)
F   12.08 (+0.33%)
MU   112.94 (-2.91%)
GE   156.61 (+0.60%)
CGC   7.95 (+22.50%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.30 (-0.47%)
PYPL   62.49 (-1.22%)
XOM   118.89 (+0.22%)
QQQ   425.93 (+0.02%)
AAPL   167.60 (-0.24%)
MSFT   409.28 (-0.62%)
META   510.20 (+3.24%)
GOOGL   156.76 (+0.83%)
AMZN   181.81 (+0.29%)
TSLA   150.10 (-3.44%)
NVDA   857.90 (+2.09%)
AMD   156.07 (+1.33%)
NIO   4.02 (+2.81%)
BABA   69.21 (+0.57%)
T   16.20 (+0.50%)
F   12.08 (+0.33%)
MU   112.94 (-2.91%)
GE   156.61 (+0.60%)
CGC   7.95 (+22.50%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.30 (-0.47%)
PYPL   62.49 (-1.22%)
XOM   118.89 (+0.22%)
QQQ   425.93 (+0.02%)
AAPL   167.60 (-0.24%)
MSFT   409.28 (-0.62%)
META   510.20 (+3.24%)
GOOGL   156.76 (+0.83%)
AMZN   181.81 (+0.29%)
TSLA   150.10 (-3.44%)
NVDA   857.90 (+2.09%)
AMD   156.07 (+1.33%)
NIO   4.02 (+2.81%)
BABA   69.21 (+0.57%)
T   16.20 (+0.50%)
F   12.08 (+0.33%)
MU   112.94 (-2.91%)
GE   156.61 (+0.60%)
CGC   7.95 (+22.50%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.30 (-0.47%)
PYPL   62.49 (-1.22%)
XOM   118.89 (+0.22%)
QQQ   425.93 (+0.02%)
AAPL   167.60 (-0.24%)
MSFT   409.28 (-0.62%)
META   510.20 (+3.24%)
GOOGL   156.76 (+0.83%)
AMZN   181.81 (+0.29%)
TSLA   150.10 (-3.44%)
NVDA   857.90 (+2.09%)
AMD   156.07 (+1.33%)
NIO   4.02 (+2.81%)
BABA   69.21 (+0.57%)
T   16.20 (+0.50%)
F   12.08 (+0.33%)
MU   112.94 (-2.91%)
GE   156.61 (+0.60%)
CGC   7.95 (+22.50%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.30 (-0.47%)
PYPL   62.49 (-1.22%)
XOM   118.89 (+0.22%)

Cronos Group (CRON) Stock Forecast & Price Target

$2.41
-0.01 (-0.41%)
(As of 12:34 PM ET)

Cronos Group Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$2.83
17.57% Upside
High Forecast$3.00
Average Forecast$2.83
Low Forecast$2.50
TypeCurrent Forecast
4/19/23 to 4/18/24
1 Month Ago
3/20/23 to 3/19/24
3 Months Ago
1/19/23 to 1/19/24
1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.83$2.67$2.75$3.17
Predicted Upside17.57% Upside34.95% Upside36.52% Upside14.87% Upside
Get Cronos Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

CRON Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRON Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cronos Group Stock vs. The Competition

TypeCronos GroupMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside16.60% Upside933.43% Upside11.75% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/8/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform ➝ Underperform$2.00 ➝ $2.50-6.72%
11/9/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$2.75 ➝ $3.00+46.70%
5/18/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Kirk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
5/15/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$3.50 ➝ $3.00+73.41%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:57 PM ET.

CRON Price Target - Frequently Asked Questions

What is Cronos Group's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Cronos Group stock is Hold based on the current 1 sell rating and 2 buy ratings for CRON. The average twelve-month price prediction for Cronos Group is $2.83 with a high price target of $3.00 and a low price target of $2.50. Learn more on CRON's analyst rating history.

Do Wall Street analysts like Cronos Group more than its competitors?

Analysts like Cronos Group less than other Medical companies. The consensus rating for Cronos Group is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how CRON compares to other companies.

Does Cronos Group's stock price have much upside?

According to analysts, Cronos Group's stock has a predicted upside of 26.71% based on their 12-month stock forecasts.

What analysts cover Cronos Group?

Cronos Group has been rated by Bank of America in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CRON) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners